QIAGEN Launches First QIAplex Products for Highly Multiplexed, PCR-Based Assays

VENLO, THE NETHERLANDS -- (MARKET WIRE) -- May 30, 2007 -- QIAGEN, the world's leading provider of sample and assay technologies for research in life sciences, applied testing, and molecular diagnostics, today announced the launch of the first assays based on its breakthrough QIAplex PCR multiplex technology. QIAplex PCR allows highly sensitive detection of multiple molecular targets in one test.
MORE ON THIS TOPIC